| Neoplastic transformation of the thyroid gland is accompanied by changes in cellular sialylation. | |
| | |
MedLine Citation:
|
PMID: 16720036 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cancer of the thyroid gland is one of the most common endocrine diseases. Histological evaluation is often complicated by difficulty in distinguishing between benign and malignant lesions. Abnormal glycosylation of cell structures, including changes in sialylation, is a feature of the neoplastic transformation process. The aim of this study was to evaluate associations between neoplastic changes in the thyroid gland and changes in sialylation, with reference to its terminal linkage type. Lectin histochemistry using three sialic acid-binding lectins: Tritrichomonas mobilensis lectin (TML), which recognizes sialic acid without linkage preference; Maackia amurensis leukoagglutinin (MAL), which preferentially binds alpha-2,3-linked sialic acid; and Sambucus nigra agglutinin (SNA), which preferentially binds alpha-2,6-linked sialic acid, were used for detection of sialylated glycoconjugates in 50 human thyroid gland specimens. These included papillary, follicular, oncocytic, medullary and anaplastic carcinomas, follicular adenomas and benign follicular and parenchymatous goiter. The luminal surface of follicular cells in normal thyroid glands, adenomas and goiters showed weak or absent labelling for sialic acid. Malignant transformation of the gland was accompanied by an increase of sialic acid positivity on follicular epithelial cells, especially of alpha-2,3-linked sialic acid. Strong luminal positivity for sialic acid was found in papillary carcinomas, whereas moderate positivity was seen in follicular carcinomas. Inconsistent, weak positivity for sialic acid was documented in medullary and anaplastic carcinomas. Increased membrane sialic acid on thyroid gland cells may be an important diagnostic pathological finding, that could be useful in distinction of malignant from benign thyroid lesions, especially with respect to aspiration cytology diagnostics. |
| | |
Authors:
|
Pavel Babál; Pavol Janega; Andrea Cerná; Ivana Kholová; Eva Brabencová |
Related Documents
:
|
3350806 - The immobilized leukoagglutinin from the seeds of maackia amurensis binds with high aff... 6884696 - Sialoglycopeptides obtained from a transplantable rat colorectal adenocarcinoma: a comp... 3115896 - Role of sialic acid in saliva-mediated aggregation of pseudomonas aeruginosa isolated f... 15454696 - Glycosphingolipids and mitochondria: role in apoptosis and disease. 9401916 - New mild acid-labile protecting groups for the guanidino function of n alpha-fluorenylm... 18473446 - Kinetic study of the hexacyanoferrate (iii) oxidation of dihydroxyfumaric acid in acid ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2006-05-23 |
Journal Detail:
|
Title: Acta histochemica Volume: 108 ISSN: 0065-1281 ISO Abbreviation: Acta Histochem. Publication Date: 2006 |
Date Detail:
|
Created Date: 2006-06-19 Completed Date: 2006-09-19 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0370320 Medline TA: Acta Histochem Country: Germany |
Other Details:
|
Languages: eng Pagination: 133-40 Citation Subset: IM |
Affiliation:
|
Department of Pathology, Faculty of Medicine, Comenius University, Bratislava, Sasinkova 4, 81372 Bratislava, Slovak Republic. pavel.babal@fmed.uniba.sk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cell Transformation, Neoplastic
/
metabolism*,
pathology Humans N-Acetylneuraminic Acid / metabolism* Thyroid Neoplasms / metabolism*, pathology |
| Chemical | |
Reg. No./Substance:
|
131-48-6/N-Acetylneuraminic Acid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Development of an innovative vertical submerged membrane bioreactor (VSMBR) for simultaneous removal...
Next Document: Critical evaluation of scientific articles and other sources of information: an introduction to evid...